Yaoping F. Shi

160# Pujian Road
Shanghai, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Expression of CREPT in vascular endothelial cells and its angiogenic mechanism in glioma

Expression of CREPT in vascular endothelial cells and its angiogenic mechanism in glioma

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: June 07, 2026

CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma.

CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 24, 2025

Triple knockdown of CD11a, CD49d, and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice.

Triple knockdown of CD11a, CD49d, and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice.

Journal: Science translational medicine

Published: January 22, 2025

Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial.

Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial.

Journal: Signal transduction and targeted therapy

Published: July 25, 2024

COVID-19 has causal effects on cancer risk? Something we might ignore.

COVID-19 has causal effects on cancer risk? Something we might ignore.

Journal: Journal of medical virology

Published: May 22, 2023

Editorial: Hepatitis B virus and host interactions in liver diseases.

Editorial: Hepatitis B virus and host interactions in liver diseases.

Journal: Frontiers in cell and developmental biology

Published: April 12, 2023

Combined local therapy and CAR-GPC3 T-cell therapy in advanced hepatocellular carcinoma: a proof-of-concept treatment strategy.

Combined local therapy and CAR-GPC3 T-cell therapy in advanced hepatocellular carcinoma: a proof-of-concept treatment strategy.

Journal: Cancer communications (London, England)

Published: December 26, 2022

360° open-ended and navigated magnetic resonance-guided microwave ablation for hepatic tumors in risk areas.

360° open-ended and navigated magnetic resonance-guided microwave ablation for hepatic tumors in risk areas.

Journal: Journal of cancer research and therapeutics

Published: October 07, 2022

Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2.

Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2.

Journal: JHEP reports : innovation in hepatology

Published: September 14, 2022

Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancer.

Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancer.

Journal: EBioMedicine

Published: August 30, 2022

Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects.

Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects.

Journal: Liver research (Beijing, China)

Published: May 31, 2022

Correction to: Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.

Correction to: Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.

Journal: European radiology

Published: March 03, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026